RHUMBLINE ADVISERS - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 61 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$155,000
+42.2%
90,953
+3.4%
0.00%
Q4 2020$109,000
+3.8%
87,928
+19.0%
0.00%
Q3 2020$105,000
-26.1%
73,860
-37.1%
0.00%
Q2 2020$142,000
+8.4%
117,343
+5.7%
0.00%
Q1 2020$131,000
-44.0%
110,9680.0%0.00%
Q4 2019$234,000
-2.9%
110,968
+1.2%
0.00%
Q3 2019$241,000
-5.1%
109,675
+9.1%
0.00%
Q2 2019$254,000
+113.4%
100,501
+166.0%
0.00%
Q1 2017$119,000
+45.1%
37,788
+19.7%
0.00%
Q4 2016$82,000
-46.4%
31,567
-20.0%
0.00%
Q3 2016$153,000
+48.5%
39,447
+2.6%
0.00%
Q2 2016$103,000
+7.3%
38,447
+54.7%
0.00%
Q1 2015$96,000
-29.4%
24,852
+23.3%
0.00%
Q4 2014$136,000
+27.1%
20,152
+3.1%
0.00%
Q3 2014$107,000
-46.5%
19,552
+0.3%
0.00%
-100.0%
Q2 2014$200,000
-6.5%
19,502
+9.6%
0.00%0.0%
Q1 2014$214,000
+2.9%
17,794
-3.4%
0.00%0.0%
Q4 2013$208,000
+4.5%
18,414
-0.5%
0.00%0.0%
Q3 2013$199,000
+17.1%
18,514
+1.1%
0.00%0.0%
Q2 2013$170,00018,3100.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
LINCOLN CAPITAL CORP 34,250$116,0000.11%
Kovack Advisors, Inc. 24,393$82,0000.02%
Cedar Wealth Management, LLC 12,000$41,0000.02%
Ausdal Financial Partners, Inc. 19,590$66,0000.02%
HRT FINANCIAL LP 15,990$53,0000.02%
Granite Investment Partners, LLC 53,853$182,0000.01%
Joel Isaacson & Co., LLC 20,000$68,0000.01%
GSA CAPITAL PARTNERS LLP 53,658$181,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 246,150$831,0000.01%
Dynamic Technology Lab Private Ltd 15,108$51,0000.01%
View complete list of ACELRX PHARMACEUTICALS INC shareholders